Moving Forward from the COVID-19 Crisis: Laboratory Trends and Challenges



 

The world has changed dramatically since the start of the COVID-19 pandemic, and this may be especially true of the clinical laboratory industry. Laboratories across the country have been caught in an extraordinary and contradictory set of circumstances—overwhelming pressure and demand for COVID-19 testing that has often been impossible to fulfill, coupled with crashing revenue and test volumes as patients across the country have been told to “shelter in place.” Join us for this webinar as the ARUP Consultative Services team speaks with a panel of laboratory leaders throughout the country to explore what’s changed in the industry, how laboratories can adapt, and what the future holds.


Lecture Presenters

Sandy Richman, MBA, C(ASCP)

Sandy Richman, MBA, C(ASCP)

Director of Consultative Services
ARUP Laboratories

Sandy Richman has nearly 20 years of combined clinical, financial, and consulting experience in the healthcare industry and is currently the director of Consultative Services for ARUP. In addition to the numerous roles Sandy has held at ARUP, he has seven years of additional healthcare consulting experience. Prior to joining ARUP, Sandy was vice president of Healthcare Advisory Services for PNC Healthcare. In this role, he worked closely with leadership teams from hospitals across the country to improve their revenue cycle and treasury management operations. Sandy also has extensive experience assisting hospitals with ED improvement, strategic planning, financial analysis, strategic pricing, operations improvement, and market research. He holds an MBA from the University of Utah, is board certified as a technologist in chemistry by the American Society for Clinical Pathology, and is a frequent speaker for the Healthcare Financial Management Association.


David Shiembob, MBA, C(ASCP)CM

David Shiembob, MBA, C(ASCP)CM

Senior Healthcare Consultant
ARUP Laboratories

David Shiembob is a senior healthcare consultant at ARUP Laboratories. He graduated from the University of Utah with a bachelor’s degree and later with a master’s degree in business administration. He is certified by the American Society for Clinical Pathology as a technologist in chemistry. He also serves on the Clinical Laboratory Scientists Council for the American Association for Clinical Chemistry. David specializes in laboratory operations, laboratory stewardship, and financial analysis and modeling.


Objectives

After this presentation, participants will be able to:

  • Discuss how the clinical laboratory landscape has changed since the beginning of the COVID-19 pandemic.
  • Identify some of the longer-term implications for the clinical laboratory industry.
  • Discuss how this crisis may have changed the public’s perception of clinical laboratories.
  • Define possible opportunities for laboratories to provide testing in the context of telehealth and digital pathology services
  • Identify ways laboratory leaders can build on an increased awareness of and reliance on clinical laboratories.

Sponsored by:

University of Utah School of Medicine, Department of Pathology, and ARUP Laboratories